Form 8-K - Current report:
SEC Accession No. 0001493152-24-049561
Filing Date
2024-12-11
Accepted
2024-12-11 08:26:23
Documents
16
Period of Report
2024-12-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40769
2 ex10-1.htm EX-10.1 25480
3 ex99-1.htm EX-99.1 10106
  Complete submission text file 0001493152-24-049561.txt   261057

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE hepa-20241210.xsd EX-101.SCH 3027
5 XBRL LABEL FILE hepa-20241210_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE hepa-20241210_pre.xml EX-101.PRE 24173
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3667
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 241540247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)